Changes in smell and taste as clinical presentation in patients with mild to moderate Coronavirus disease
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/026122
- Lead Sponsor
- Kalinga Institute of Medical Sciences Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients >18years of age, diagnosed with mild to moderate COVID-19 (not requiring ICU care) and are clinically able to fulfil the questionnaire
Exclusion Criteria
Patients < 18 years of age, diagnosed with severe COVID, requiring ICU care and unable to fulfil the questionnaire
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determining the occurrence of olfactory and gustatory alterations in patients with laboratory confirmed mild to moderate COVID-19 infection admitted to a tertiary COVID care hospitalTimepoint: The patient will be assessed on the day of admission to the COVID hospital, (taken as baseline), assuming the day of admission to the hospital as the day of detection as COVID positive. The patient will then be followed up after 2 weeks and 3 weeks from baseline to assess the resolution of symptoms. This is so because most of the studies have revealed that majority of the symptoms subside by 2-3 weeks in patients with mild to moderate COVID disease.
- Secondary Outcome Measures
Name Time Method Identifying the timing of occurrence of olfactory and gustatory dysfunctions in relation to the diagnosis of COVID-19, identifying the degree of severity of olfactory and gustatory dysfunctions in relation to the COVID-19 and to co-relate and analyse whether these symptoms can ne use as a indicator of underlying COVID-19 during the currently ongoing pandemic. <br/ ><br>Timepoint: At 7 days after discharge from the hospital